Stage lighting on PAR-1: a step further in the understanding of acquired focal and segmental glomerulosclerosis - Université Paris-Est-Créteil-Val-de-Marne Access content directly
Journal Articles Kidney International Year : 2023

Stage lighting on PAR-1: a step further in the understanding of acquired focal and segmental glomerulosclerosis

Abstract

The pathogenic mechanisms of acquired focal and segmental glomerulosclerosis are only partially known and represent a medical challenge in nephrology. The article by May et al. sheds additional light on previous data indicating the key role of the protease activated receptor 1. The new evidence is based on in vivo studies in relevant animal models and on patient biopsies and represents a significant step forward in the understanding of this pathological condition.
Fichier principal
Vignette du fichier
KI HAL version.pdf (238.88 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-04188146 , version 1 (25-08-2023)

Identifiers

Cite

Mario Ollero, Dil Sahali. Stage lighting on PAR-1: a step further in the understanding of acquired focal and segmental glomerulosclerosis. Kidney International, 2023, 104 (2), pp.234-236. ⟨10.1016/j.kint.2023.04.016⟩. ⟨hal-04188146⟩

Collections

INSERM IMRB UPEC
9 View
33 Download

Altmetric

Share

Gmail Facebook X LinkedIn More